Default company panoramic image
Logo

Viewpoint Molecular Targeting

Viewpoint has developed a patented image-guided therapy for metastatic melanoma that is poised for Phase I clinical trials in humans.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Iowa City, IA, USA
  • Currency USD
  • Founded October 2008
  • Employees 3
  • Website viewpointmt.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.